Akari Therapeutics ADR
(AKTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2014 | 12-2013 | 06-2013 | 12-2012 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 0 | 7,650 | 1 | 1,100 |
| Receivables | 0 | 170 | 60 | 10 |
| Other current assets | 0 | 10 | -1 | 0 |
| TOTAL | $0 | $7,830 | $60 | $1,110 |
| Non-Current Assets | ||||
| PPE Net | N/A | 10 | N/A | N/A |
| TOTAL | $N/A | $10 | $N/A | $N/A |
| Total Assets | $0 | $7,830 | $60 | $1,120 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 1,230 | 3,260 | 2,950 |
| TOTAL | $0 | $1,230 | $3,260 | $3,850 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 0 | 780 | 1,830 | 630 |
| TOTAL | $N/A | $780 | $1,830 | $630 |
| Total Liabilities | $0 | $2,010 | $5,090 | $4,480 |
| Shareholders' Equity | ||||
| Common Shares | 0 | 670 | 250 | 240 |
| Retained earnings | 0 | -20,540 | -19,610 | -16,920 |
| Other shareholders' equity | 0 | 0 | 10 | 130 |
| TOTAL | $0 | $5,810 | $-5,020 | $-3,360 |
| Total Liabilities And Equity | $0 | $7,820 | $70 | $1,120 |